ES2018502T5 - Adhesivo tisular de un solo componente asi como procedimiento para su preparacion. - Google Patents

Adhesivo tisular de un solo componente asi como procedimiento para su preparacion.

Info

Publication number
ES2018502T5
ES2018502T5 ES87109374T ES87109374T ES2018502T5 ES 2018502 T5 ES2018502 T5 ES 2018502T5 ES 87109374 T ES87109374 T ES 87109374T ES 87109374 T ES87109374 T ES 87109374T ES 2018502 T5 ES2018502 T5 ES 2018502T5
Authority
ES
Spain
Prior art keywords
procedure
preparation
well
single component
tissue adhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87109374T
Other languages
English (en)
Other versions
ES2018502B3 (es
Inventor
Norbert Prof Dr Heimburger
Peter Dr Fuhge
Hansjorg Dr Ronneberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centeon Pharma GmbH
Original Assignee
Centeon Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6304482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2018502(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centeon Pharma GmbH filed Critical Centeon Pharma GmbH
Application granted granted Critical
Publication of ES2018502B3 publication Critical patent/ES2018502B3/es
Publication of ES2018502T5 publication Critical patent/ES2018502T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Glass Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UN TEJIDO ADHESIVO DE COMPONENTES QUE COMPRENDE EN DISOLUCION ACUOSA FIBRINOGENO, F XIII, UN INHIBIDOR DE TROMBINA, FACTORES DE PROTROMBINA, CALCIUMIONES Y DADO EL CASO UN INHIBIDOR DE PLASMA, ASI COMO UN PROCEDIMIENTO PARA SU FABRICACION. ESTE ADHESIVO PUEDE RECONSTITUIRSE DE UNA FORMA LIOFILIZADA CON AGUA. PUEDE COMPRENDER TODAS LAS SUSTANCIAS ACTIVAS EN FORMA PASTEURIZADA Y ESTA ADEMAS LIBRE DE RIESGO DE TRANSMISION DE UNA HEPATITIS Y HTLV III.
ES87109374T 1986-07-05 1987-06-30 Adhesivo tisular de un solo componente asi como procedimiento para su preparacion. Expired - Lifetime ES2018502T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863622642 DE3622642A1 (de) 1986-07-05 1986-07-05 Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
ES2018502B3 ES2018502B3 (es) 1991-04-16
ES2018502T5 true ES2018502T5 (es) 1999-10-01

Family

ID=6304482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87109374T Expired - Lifetime ES2018502T5 (es) 1986-07-05 1987-06-30 Adhesivo tisular de un solo componente asi como procedimiento para su preparacion.

Country Status (12)

Country Link
US (2) US5407671A (es)
EP (1) EP0253198B2 (es)
JP (1) JP2511462B2 (es)
AT (1) ATE56883T1 (es)
AU (1) AU610504B2 (es)
CA (1) CA1321138C (es)
DE (2) DE3622642A1 (es)
DK (1) DK174332B1 (es)
ES (1) ES2018502T5 (es)
FI (1) FI90826C (es)
GR (2) GR3001226T3 (es)
PT (1) PT85242B (es)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
FR2650508A1 (fr) * 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US7229959B1 (en) 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6613324B1 (en) * 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
WO1993005822A1 (en) * 1991-09-27 1993-04-01 Octapharma Ag Tissue glue prepared by using cryoprecipitate
EP0534178B1 (en) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Improved tissue glue prepared by using cryoprecipitate
DE4202667C1 (es) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
EP0885020A1 (en) * 1996-02-20 1998-12-23 Cohesion Corporation Tissue sealant compositions and methods of use thereof
DE19607239A1 (de) * 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
JP2002514960A (ja) 1997-06-18 2002-05-21 コヘージョン テクノロジーズ，インコーポレイテッド トロンビンおよびミクロフィブリルコラーゲンを含む組成物、ならびにその調製および使用の方法
AT406120B (de) 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
DE19851334C2 (de) * 1998-11-06 2000-09-28 Aventis Behring Gmbh Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung
US6310036B1 (en) 1999-01-09 2001-10-30 Last Chance Tissue Adhesives Corporation High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces
JP3937423B2 (ja) * 1999-01-19 2007-06-27 ニプロ株式会社 アミノ酸含有アルブミン製剤
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
DE10204405A1 (de) * 2002-02-04 2003-08-21 Surface Care Gmbh Plasmagel
AU2003226265A1 (en) * 2002-04-05 2003-10-27 Baxter Healthcare S.A. Storage stable liquid sealer protein complex
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
DE10261126A1 (de) 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
AU2003270401B2 (en) 2002-09-10 2008-03-13 American National Red Cross Hemostatic dressing
US20040243044A1 (en) * 2003-06-02 2004-12-02 Penegor Stephen A. Hemostatic wound dressing
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
US20050075718A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
WO2005046528A1 (en) 2003-10-06 2005-05-26 3F Therapeutics, Inc. Minimally invasive valve replacement system
JP2005239613A (ja) * 2004-02-25 2005-09-08 Asahi Kasei Medical Co Ltd フィブリノーゲン組成液及びその製法
KR100624013B1 (ko) * 2004-06-25 2006-09-19 주식회사 녹십자홀딩스 동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
ES2221817B1 (es) * 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
EP1848472B1 (en) 2005-02-07 2015-04-01 Hanuman LLC Platelet rich plasma concentrate apparatus and method
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2063831A4 (en) 2006-08-04 2010-10-06 Stb Lifesaving Technologies In SOLID FIRM FOR THE TREATMENT OF WOUND FABRICS
ES2485901T3 (es) * 2007-03-22 2014-08-14 The Chemo-Sero-Therapeutic Research Institute Preparación sólida de fibrinógeno
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2146794B1 (en) 2007-04-12 2016-10-19 Biomet Biologics, LLC Buoy suspension fractionation system
WO2009020612A1 (en) 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Methods and dressing for sealing internal injuries
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9433700B2 (en) 2009-04-27 2016-09-06 Medibeacon Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
AU2011260258B2 (en) 2010-06-01 2015-07-09 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
CN107427601B (zh) 2015-03-27 2021-08-31 3M创新有限公司 纤维蛋白组合物、方法和伤口用制品
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods
WO2017083248A1 (en) * 2015-11-11 2017-05-18 Ethicon, Inc. Sealant formulation and uses thereof
IL247786B (en) 2016-09-12 2019-08-29 Plotkin Alexander Covers the wound with a hemostatic action and method and creates it
US12090247B2 (en) 2016-09-12 2024-09-17 Alexander Plotkin Water-soluble sealant composition and its preparation
US10940233B2 (en) 2016-10-05 2021-03-09 3M Innovative Properties Company Fibrinogen composition, method and wound articles
EP3522942B1 (en) 2016-10-05 2023-12-27 3M Innovative Properties Company Fibrin composition comprising carrier material, method and wound articles
WO2018146235A1 (en) 2017-02-09 2018-08-16 Csl Behring Gmbh A blood coagulation factor replacement product for use in the treatment or prophyl of bleedings

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5558163A (en) * 1978-10-24 1980-04-30 Unitika Ltd Material for treating wounded portion
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
JPS5844057A (ja) * 1981-08-28 1983-03-14 ユニチカ株式会社 創傷部治療用材料
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
JPS5980253A (ja) * 1982-10-28 1984-05-09 ユニチカ株式会社 創傷部治療用材料

Also Published As

Publication number Publication date
EP0253198B1 (de) 1990-09-26
FI90826C (fi) 1994-04-11
DK174332B1 (da) 2002-12-09
PT85242A (de) 1987-08-01
GR3030989T3 (en) 1999-12-31
DE3622642A1 (de) 1988-01-14
JPS6324951A (ja) 1988-02-02
US6500427B1 (en) 2002-12-31
DE3765194D1 (de) 1990-10-31
PT85242B (pt) 1990-03-30
AU610504B2 (en) 1991-05-23
CA1321138C (en) 1993-08-10
AU7509787A (en) 1988-01-07
DK342887A (da) 1988-01-06
FI90826B (fi) 1993-12-31
EP0253198B2 (de) 1999-06-23
FI872926L (fi) 1988-01-06
US5407671A (en) 1995-04-18
GR3001226T3 (en) 1992-07-30
DK342887D0 (da) 1987-07-03
ATE56883T1 (de) 1990-10-15
ES2018502B3 (es) 1991-04-16
EP0253198A1 (de) 1988-01-20
JP2511462B2 (ja) 1996-06-26
FI872926A0 (fi) 1987-07-02

Similar Documents

Publication Publication Date Title
ES2018502B3 (es) Componentes de tejido adhesivo asi como procedimiento para su fabricacion.
NO20002357L (no) Fibrin-tetningsmidler eller -ad-hesiver inneholdende et hyaluronsyrederivat-materiale
CO5040226A1 (es) Producto de braga absorbente
DE60006361D1 (de) Mehrschichtige prothese zur chirurgischen behandlung von inguinalhernia
DE69724958D1 (de) Verfahren zur sterilisierung in diffusionsbeschrankten umgebunden
DK0835667T3 (da) Vævklæbemiddel egnet til spröjtepåföring
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
NO971568L (no) Analoger av keratinocyttvekstfaktor
BR9808181A (pt) Uso de um conservante de madeira e envoltório para a proteção suplementar de madeira
FI865159A0 (fi) Kompositioner som innehaoller en stabiliserad aktivator foer maenniskans vaevnadsplasminogen.
ES2056497T3 (es) Solucion para infusion y dialisis que contiene bicarbonato y calcio.
AU3206493A (en) Stabile fibrinogen solution
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
ES2170158T3 (es) Composiciones topicas que contienen n-acetil-l-cisteina.
ES2052718T3 (es) Composicion desinfectante y esterilizante.
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
MX9302487A (es) Piridonas sustituidas por bifenilmetilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2093944T3 (es) Composicion cosmetica y/o dermatologica de accion despigmentante que contiene un acido di- o tri-cafeoilquinico o una mezcla de estos.
ATE201823T1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
ES2012573A6 (es) Una composicion fungicida activa en el control de hongos fitopatogenos, en particular oomicetos.
DK318589D0 (da) 19-substituerede progesteron-derivater, anvendelige som 19-hydroxylase-inhibitorer
DE69832066D1 (de) Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
AR015861A1 (es) Mezclas fungicidas y el procedimiento para controlar hongos nocivos con dichas mezclas
AR006855A1 (es) Mezclas fungicidas sinergicas, utiles para combatir hongos fitopatogenos y el procedimiento de aplicacion de dichas mezclas.
ES2159621T3 (es) Composiciones farmaceuticas que comprenden hirudina.